Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Greece bans export of 25 drugs after pharmacists' supply warnings

Tue, 14th Jul 2015 17:14

(Adds AstraZeneca comment)

By Lefteris Karagiannopoulos

ATHENS, July 14 (Reuters) - Greece has decided to ban theexport of 25 types of drugs, the Health Ministry said onTuesday, following warnings of possible shortages that riskedleading to a humanitarian crisis.

A ministry spokeswoman quoted the Greek drugs regulator assaying there had been a significant increase in some importedmedicines being shipped back out of the country.

"Abuses by some players in the pharmaceuticals market havebeen discovered," she told Reuters.

The regulator made the warning on re-exports during ameeting at the Health Ministry on Friday, when pharmacistscomplained they faced difficulties in securing some supplies.

The spokeswoman said the ministry would closely checkexports and re-exports over the past 15 days and file complaintsat home and abroad where there is evidence of abuse. Shedeclined to say which drugs would be included in the ban.

However, the head of the drugs wholesalers' association saidthe group had not yet been informed of the ban.

The ban was the latest move in a row over the availabilityof drugs in Greece, with pharmacists, drugmakers, wholesalersand public authorities trading blame while rights group warn ofworsening public health conditions during the economic crisis.

Difficulties over drug supplies in Greece are compounded bycapital controls which prevent companies from sending moneyabroad, imposed last month to prevent the banking system fromcollapse.

Re-exporting drugs across European borders, which allowstraders to buy products in low-cost markets and sell them whereprices are higher, is permitted under European Union free traderules.

Drugmakers have nevertheless urged a curb on re-exports toprevent shortages in Greece but wholesalers trading medicineshave denied the need for such emergency action.

The European Federation of Pharmaceutical Industries andAssociations (EFPIA), which represents 40 drug companies, calledon Tuesday for "exceptional measures" in "exceptionalcircumstances".

"A proportionate, legislative ban on exporting medicinesintended for Greek patients from Greece would be an appropriateand justifiable response to possible shortages and help to averta potential humanitarian crisis," it said in a statement.

But the head of the Hellenic Association of MedicineWholesalers, Eirini Markaki, pointed the finger at internationaldrugmakers and pharmacists. "Most of the internationalpharmaceutical companies have issued quotas on the amount ofsupplies Greek warehouses can order," Markaki told Reuters.

"We have filed official complaints to the regulator so thatmeasures are taken for this to stop," she said, adding that thecomplaints targeted AstraZeneca, Novartis andJanssen, a unit of Johnson & Johnson. Novartis deniedthat it had limited its supplies to Greece, while Janssen wasnot immediately available for comment.

ASTRAZENECA DENIAL

A spokesperson for AstraZeneca said the firm had met theregulator last week "to dispute the allegations made by theHellenic Association of Pharmaceutical Warehouses".

At that meeting, AstraZeneca said, it had "provided evidenceto demonstrate that we continue to deliver in excess of thequantities of medicines currently required in the Greek market".

Markaki denied any overall increase in re-exports bywholesalers. She said an isolated case of one warehouseexporting 700,000 units of drugs in two days at the end of Junewas under investigation, but all the warehouses combined hadexported only 179,000 items so far in July.

Demand for drugs had increased because customers were tryingto build up their supplies, fearing future shortages, she added.

The pharmaceuticals industry is owed more than 1.1 billioneuros by Greek hospitals and the state-run health insurer inunpaid bills since December but it has promised to keep supplylines open on humanitarian grounds.

Separately, Greek pharmacists will go on strike on Wednesdayto protest about plans in a deal struck between Athens and itsinternational lenders on Monday to make changes to their trade.These include allowing people without a pharmacist's degree toopen a pharmacy. (Additional reporting by Kate Kelland in London; Writing byIngrid Melander; Editing by David Stamp)

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.